Compare NCSM & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NCSM | BNR |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.0M | 119.2M |
| IPO Year | 2017 | 2019 |
| Metric | NCSM | BNR |
|---|---|---|
| Price | $44.17 | $9.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.9K | ★ 23.0K |
| Earning Date | 04-29-2026 | 06-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 239.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $142,471,000.00 | N/A |
| Revenue This Year | $5.57 | $111.65 |
| Revenue Next Year | $4.81 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $29.48 | $4.75 |
| 52 Week High | $87.36 | $41.72 |
| Indicator | NCSM | BNR |
|---|---|---|
| Relative Strength Index (RSI) | 40.78 | 44.33 |
| Support Level | $42.66 | $8.00 |
| Resistance Level | $45.87 | $10.00 |
| Average True Range (ATR) | 1.26 | 1.00 |
| MACD | 0.04 | 0.31 |
| Stochastic Oscillator | 32.42 | 30.45 |
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completion, and field development strategies. The company provides its products and services to E&P companies for use in onshore and offshore wells, predominantly those drilled with horizontal laterals in unconventional and conventional oil and natural gas formations. It also provides tracer diagnostics services and sells products for well construction including casing buoyancy systems, liner hanger systems and toe initiation sleeves, along with certain complementary products from third parties. The company operates in the United States, Canada and other countries, with the majority of its revenue generated from Canada.
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.